GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

ABVC Biopharma ABVC · USD

N/A · US listing · 🇺🇸 United States

Compare

0.97

-2.88%

Close of 5 Nov 2026, in USD

Latest on ABVC Biopharma

Our reporting

We have not reported on ABVC Biopharma yet.

Next results

16 Nov 2026

Due on 16 Nov 2026. Analysts expect earnings of -0.40 a share on revenue of $113,257.

Past results

Reported against what analysts expected

30 Oct 202612 Aug 202618 May 202629 Apr 20263 Mar 202631 Oct 2025
Earnings per share-0.05-0.03-0.06-0.06-0.12-0.05
Forecast—-0.40———-0.40
Revenue————−$795,950—
Forecast—$113,257———$300,000

Key events

  1. 25 Jul 202310-to-1 reverse split
  2. 8 May 201918-to-1 reverse split
  3. 11 Apr 20163.141-for-1 share split
  4. 13 Aug 20155000-to-1 reverse split
  5. 18 Feb 20115-to-1 reverse split
  6. 19 Jun 20071.5733-for-1 share split

ABVC Biopharma in the news

Headlines from other publishers, linked to their own pages.

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.